| Publication Date | Title | Author(s) |
| 31-Jul-2015 | Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma | Matsuo, K; Hasegawa, K; Yoshino, K; Murakami, R; Hisamatsu, T, et al |
| 10-Jan-2017 | CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites | Sood, D; Johnson, N; Jain, P; Siskos, AP; Bennett, M, et al |
| 28-Apr-2016 | Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity | Lubecka, K; Kurzava, L; Flower, K; Buvala, H; Zhang, H, et al |
| 24-Mar-2017 | Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is down-regulated in metaplastic breast cancer | Yague, E; Asaduzzaman, M; Constantinou, S; Haoxiang, M; Gallon, J, et al |
| 1-Jun-2015 | Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer | Zhang, H; Angelopoulos, N; Xu, Y; Grothey, A; Nunes, J, et al |
| 25-Oct-2014 | Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway | Alshaker, H; Krell, J; Frampton, AE; Waxman, J; Blyuss, O, et al |
| 12-Nov-2013 | SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1 | Zhang, H; Xu, Y; Filipovic, A; Lit, LC; Koo, C-Y, et al |
| 17-Sep-2013 | 'Being there' for women with metastatic breast cancer: a pan-European patient survey | Harding, V; Afshar, M; Krell, J; Ramaswami, R; Twelves, CJ, et al |
| 11-Jun-2014 | Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells | Lombardo, Y; Faronato, M; Filipovic, A; Vircillo, V; Magnani, L, et al |
| 30-Apr-2013 | Circulating microRNAs as potential new biomarkers for prostate cancer | Sita-Lumsden, A; Dart, DA; Waxman, J; Bevan, CL |